News

CDC director says this is not mandatory, but is a road map and provides strategies for schools to reopen safely.

Decision comes as Biden states all Americans won’t be vaccinated by the end of summer.

Just months removed after its last outbreak, the country is seeing the emergence of another outbreak.

New CDC guidance highlights the importance of shingles vaccine, yet numbers suggest demand for it may be on decline.

Do people of varying age groups look at wearing a face mask differently?

Proper assessment of the severity and extent of pulmonary involvement is of paramount importance.

Evidence shows demographic structure and age-specific contacts play an essential role in the epidemic.

Patients with severe COVID-19 experienced positive benefits reducing mortality and intubation rates when using the therapy along with Decadron and convalescent plasma.

Quality face masks remain an important part of our fight against the virus, as most people are still unvaccinated. New virus variants may mean extended mask wearing.

A pair of experts assess literature on the means of interpreting hospitalized patient antibiotic resistance through machine learning.

Derek Blechinger, MD, MPH, and a team at the Kaiser Permanente San Francisco Medical Center have developed an HIV prediction model to find patients earlier in the care cycle who could benefit from pre-exposure prophylaxis (PrEP) therapy.

The country announced it is going to study the use of the Johnson & Johnson vaccine for health care workers and will not go forward with plans to use the AstraZeneca vaccine.

The Centers for Disease Control and Prevention (CDC) weighs in on this topic in light of the new variants.

Notable differences exist between the 2 sedation agents, but those differences do not appear to impact outcomes.

An assessment of a comparative study between leading options for a burdensome infection.

The EUA follows the authorization for lone therapy bamlanivimab for adults and children at risk of severe COVID-19.

The UK announced it is beginning a 2-dose study using one dose of the Pfizer/BioNTech and one dose of AstraZeneca in each individual participant.

In most areas tested, the algorithm's estimates of infections corresponded to the percentage of people who had tested positive for antibodies.

Positives that participants identified were associated with less anxiety and improved well-being.

An orally administered adsorbent to prevent antibiotic disruption of intestinal flora enters phase 3 trial against clostridium difficile (C diff) in patients with hematologic malignancies.

Our editor-in-chief rates the first year of response to the pandemic.

Health care workers hospitalized with COVID-19 showed no greater risk than the general public for mechanical ventilation or death, and may actually have less risk of ICU admission and shorter hospital stays, a new study found.

A new study focused on age-specific trends within the US as a way to address targeted COVID-19 intervention efforts.

Iran reports 7,300 new cases as vaccination program is set to begin.

The two-dose vaccine's ineffective prevention of the more transmissible virus variant led to official seeking better options—and broader outcomes.

Implications for antimicrobial use and antimicrobial resistance.

A small study focused on patients' infection response from symptom onset to recovery or death.

Contemporary care guidelines for this bacterium in geriatrics needs to be followed more closely, one study found.

Study outlines differences in health, access to care, among other factors.